Document:

Exhibit 10.7

 

 

CONSULTING AGREEMENT

 

THIS CONSULTING AGREEMENT (the “Agreement”) dated July 1, 2017

 

AMONG:

 

Zomedica Pharmaceuticals Corp.,

a corporation formed and governed under the laws of the Province
of Alberta,

with a municipal address of 3928 Varsity Drive, Ann Arbor, MI 48108

(the “Parent”)

 

-AND-

 

Zomedica Pharmaceuticals Inc.,

a corporation formed and governed under the laws of the State of
Delaware,

with a municipal address of 3928 Varsity Drive, Ann Arbor, MI 48108

(the “Company”)

 

-AND-

 

William C. MacArthur,

an individual residing at

7373 Donegal Dr., Onsted, MI 49265

(the “Contractor”).

 

BACKGROUND:

 

		A.	The Contractor previously served as an officer and director of each of the Parent
and the Company and was employed by the Company pursuant to an agreement dated on or about October 1, 2015, together with an addendum
thereto dated on or about October 1, 2015 (collectively, the "Employment Agreement").

 

		B.	The Contractor has tendered his resignations as an officer and director of each of
the Company and the Parent.

 

		C.	The Employment Agreement has been terminated and all amounts owing thereunder (whether
by contract or operation of law) have been settled in full.

 

		D.	The Company believes the Contractor has the necessary qualifications, experience and
abilities to provide certain services to the Company, as set forth in this Agreement.

 

		E.	The Contractor is agreeable to providing the Services described herein to the Company
on the terms and conditions set out in this Agreement.

 

IN CONSIDERATION OF the matters described above and of the mutual benefits and obligations
set forth in this Agreement, the receipt and sufficiency of which considerations is hereby acknowledged, the Parent, the Company
and the Contractor (individually the “Party” and collectively the “Parties” to this Agreement) agree as
follows:

 

Services Provided

 

		1.	The Company hereby agrees to engage the Contractor as an independent contractor to
provide the Company with services below (the “Services”) (with the specifics of such Services to be determined and
directed by the CEO of the Company) consisting of:

 

     

     

    

 

	a.		Develop and Update Research Plan;

 

	b.		Assay Development;

 

	c.		Equipment evaluation and purchase/sell recommendations;

 

	d.		Design and execute experiments.

 

	e.		Prepare documentation to enable counsel to file documents for intellectual property
(IP) protection as mutually agreed by management.

 

	f.		Prepare briefs as needed to keep management informed of important developments in
R&D, and to capture developments from research efforts, or as directed by the CEO and/or Board of Directors.

 

	g.		Provide scopes of work to include: timelines, budgets, and deliverables.

 

	h.		Provide such other professional services as may reasonably be requested by the CEO.

 

Terms of Agreement

 

		2.	The term of this Agreement (the “Term”) will begin on the date of this
Agreement (as first written above) and will, subject to earlier termination as provided in this Agreement, remain in full force
and effect for a period of one year (or the earlier completion of the Services). The Term of this Agreement may be extended with
the written consent of both Parties.
	 	 	 

		3.	In the event that either Party wishes to terminate this Agreement at any time, whether
during the Term or any extension thereof, the Party will be required to provide 30 days written notice to the other Party, following
which this Agreement shall be deemed to have been terminated.

 Performance

 

		4.	The Parties agree to do everything necessary to ensure that the terms of this Agreement
take effect.

 

Currency

 

		5.	Except as otherwise provided in this Agreement, all monetary amounts referred to in
this Agreement are in US Dollars.

 

Compensation

 

		6.	For the services rendered by the Contractor as required by this Agreement, the Company
will provide compensation (the “Compensation”) to the Contractor of $200.00 per hour.
	 	 	 

		7.	The Company will be invoiced monthly.
	 	 	 

		8.	The Contractor shall be responsible for all taxes payable as a result of the provision
of the Services or which arise out of this Agreement.
	 	 	 

		9.	Invoices
submitted by the Contractor to the Company are due within 30 days of Receipt.

 

     

     

    

Reimbursement of Expenses

 

		10.	The
Contractor will be reimbursed for any expenses, including travel, supplies and fees reasonably incurred in connection with providing
the Services of this Agreement with prior approval from Zomedica (such approval not to be unreasonably withheld).

 

Confidentiality 

 

		11.	Confidential
information (the “Confidential Information”) refers to any and all data or information relating to the business of
the Company that would reasonably be considered to be proprietary to the Company including, but not limited to, accounting records,
business processes, and client records and that is not generally known in the industry of the Company and where the release of
that Confidential Information could reasonably be expected to cause harm to the Company. However, nothing in this agreement shall
prohibit contractor from complying with applicable legal or regulatory requirements provided that contractor provide a prompt
notice to Company so that Company may seek a protective order or appropriate remedy.
	 	 	 

		12.	The
Contractor agrees that he will not disclose, divulge, reveal, report or use, for any purpose, any Confidential information which
the Contractor has obtained, except as authorized by the Company or as required by law. The obligations of confidentiality will
apply during the term of this Agreement and will survive indefinitely upon termination of this Agreement.
	 	 	 

		13.	All
written and oral information and material disclosed or provided by the Company to the Contractor under this Agreement is Confidential
Information regardless of whether it was provided before or after the date of this Agreement or how it was provided to the Contractor.

 

 

 

 

     

     

    

Ownership of Intellectual Property

 

		14.	All
intellectual property and related material (the “Intellectual Property”) that is developed or produced under this
Agreement, will be the sole property of the Company. The use of the Intellectual Property by the Company will not be restricted
in any manner.
	 	 	 

		15.	The
Contractor may not use the Intellectual Property for any purpose other than that contracted for this Agreement except with the
written consent of the Company. If unauthorized use of the Intellectual Property is proven, the Contractor will be responsible
for any and all damages resulting from said use. In the course of Contractor's consultancy with the Company, Contractor may have
access to information or materials that are considered trade secret, confidential and/or proprietary by the Company (“Information”).
Information permits the development and commercialization of competitive and unique products and services, and is protected by
the Company from unauthorized use and disclosure. Information includes, but is not limited to, technical know-how, procedures,
technical specifications, designs, software (both object code and source code), results of testing, programmer documentation,
protocols, processes, compilations of data, strategic plans, sales and marketing plans, product plans, customer information, supplier
information, financial information and proposed agreements. Information also includes all written materials identified in writing
as “Confidential” or “Proprietary” or such similar proprietary legend, and oral information disclosed
in connection with the Information. This Information relates to the heart of the Company’s operation and is protected from
unauthorized use and disclosure. It is important for the Company, and for the entities with whom it has contractual relationships,
that the Information be maintained in confidence and only be disclosed at the direction of the Company’s officers and authorized
agents.
	 	 	 

		16.	Contractor
agrees to keep Information of the Company confidential. Contractor agrees that, unless otherwise directed by the Company, during
and after Contractor's consultancy Contractor will not: (a) take, retain or use Information or Company materials for Contractor's
own benefit; (b) disclose Information to any other entity or unauthorized person without the written permission from a Company
officer; (c) delete, encrypt, password protect, or retain electronic files containing Information or Company materials (including
emails and attachments); or (d) take any other action that impairs, restricts, limits, or impedes the Company’s ability
to have full access to and use of its Information and materials. In addition, upon termination of Contractor's consultancy hereunder,
Contractor agrees to return to the Company all Information and Company materials, and otherwise fully cooperate with and assist
the Company in ensuring the Company’s ability to have full access to and use of its Information and materials. Such cooperation
and assistance may include, but is not limited to, removing any password protection, encryption or other proprietary format on
Company Information and/or materials.

 

     

     

    

		17.	Contractor
has no obligation to maintain as confidential any Information that is or becomes entirely in the public domain, or is known to
Contractor prior to disclosure by the Company as evidenced by written, dated records in Contractor's possession, or is received
lawfully by Contractor without the breach of any obligation of confidentiality owed to the Company. The fact that discrete elements
of Company confidential information may be in the public domain does not, by itself, remove from the protections of this Agreement
any Information combining such discrete elements with other information and technology.
	 	 	 

		18.	Contractor
may also have access to information that is considered confidential by third parties with whom the Company does business, such
as customers, suppliers, and consultants (“Clients”). Such Client information shall be maintained as confidential
in accordance with the procedures, all applicable laws, and any contractual confidentiality obligations imposed by the Company’s
Clients. Contractor also shall comply with any intellectual property provisions contained in any of the Company’s agreements
with its Clients.
	 	 	 

		19.	The
Company understands that its current consultants may have had access to the trade secrets and proprietary information of third
parties (that is, persons or companies other than the Company) during their previous consultancy. These other trade secrets may
be owned by the former employers or by clients with whom those former employers did business. The Company does not permit its
consultants to disclose, use or incorporate into the Company’s Information, products or services, the unlicensed trade secrets
or proprietary information of third parties. Contractor acknowledges the foregoing, and represents and warrants that Contractor
will not disclose to the Company, or incorporate into the Company Information, products or services, any trade secrets or proprietary
information of third parties.
	 	 	 

		20.	The
confidentiality provisions of this Agreement shall survive termination of the consultancy relationship with the Company and shall
survive for so long a period of time as the Information is maintained by the Company as confidential.

 

Disclosure and Ownership of Workproduct and Information.

 

		21.	Contractor
agrees to disclose promptly to the Company all ideas, inventions (whether patentable or not), improvements, copyrightable works
of original authorship (including but not limited to computer programs, compilations of information, generation of data, graphic
works, audio-visual materials, technical reports and the like), trademarks, know-how, trade secrets, processes and other intellectual
property, developed or discovered by Contractor in the course of Contractor's consultancy relating to the business of the Company,
or to the prospective business of the Company, or which utilizes the Company Information or staff services (collectively, “Workproduct”).

			 

		22.	Workproduct
created by Contractor within the scope of Contractor's consultancy, on Company time, or using Company resources (including but
not limited to facilities, staff, Information, time and funding), belongs to the Company and is not owned by Contractor individually.
Contractor agrees that all works of original authorship created during Contractor's consultancy are “works made for hire”
as that term is used in connection with the U.S. Copyright Act. To the extent that, by operation of law, Contractor retains any
intellectual property rights in any Workproduct, Contractor hereby assigns to the Company all right, title and interest in all
such Workproduct, including copyrights, patents, trade secrets, trademarks and know-how.

			 
	

     

     

    

	 	 	 

		23.	Contractor
agrees to cooperate with the Company, at the Company’s expense, in the protection of the Company Information and the securing
of the Company’s proprietary rights, including signing any documents necessary to secure such rights, whether during or
after Contractor's consultancy with the Company, and regardless of the fact of any consultancy with a new company.

			 

Nonsolicitation of Company Employees.

 

		24.	Contractor
acknowledges that the relationships between the Company and its employees are valuable assets of the Company. During Contractor's
consultancy and for a period of two (2) years after termination of Contractor's consultancy, Contractor agrees not to hire, use,
or contract with (or to solicit for hire, use or to contract with) any individual(s) employed by the Company, or who left their
employment at the Company during Contractor's consultancy with the Company or within ninety (90) days after Contractor's last
day of consultancy (collectively, “Staff”). During Contractor's consultancy and for a period of two (2) years after
termination of Contractor's consultancy, Contractor agrees not to contact Staff (or have someone else contact Staff) for the purpose
of terminating their relationship with the Company or offering consultancy opportunities outside of the Company.

			 

Nonsolicitation of Company Customers. 

 

		25.	Contractor
acknowledges that the relationships between the Company and its customers are valuable assets of the Company. During Contractor's
consultancy and for a period of two (2) years after termination of Contractor's consultancy, Contractor agrees that Contractor
will not contact (or have someone else contact) any then-current Company customer (or prospective customer with whom the Company
is negotiating or preparing a proposal for products or services)(collectively, Company “Customers”) for the purposes
of: (a) inducing them to terminate their business relationship with the Company; (b) discouraging them from doing business with
the Company; or (c) offering products or services that are similar to or competitive with those of the Company. “Contact”
with any Customer includes responding to contact initiated by the Customer. These prohibitions cover solicitations or contact
by Contractor whether on Contractor's own behalf, as an employee of a third party, as an independent contractor, as a consultant,
or any other status.

			 

Prohibition of Work for Company Customers. 

 

		26.	Because
of the valuable relationships the Company has with its Customers, Contractor agrees that, during Contractor's consultancy and
for a period of two (2) years after termination of Contractor's consultancy, Contractor will not provide products or services
for, or accept a position with, any Company Customer to whom Contractor or the Company provided products and/or services while
Contractor was employed with the Company, unless specifically authorized in writing by a Company officer. These prohibitions cover
services provided by Contractor whether as an employee for the Customer, employee for a third party, independent contractor, consultant,
or any other status.

			 

     

     

    
 Non-Competition.

 

		27.	During
Contractor's consultancy and for a period of two (2) years after termination of Contractor's consultancy, Contractor agrees not
to provide, either directly or indirectly, any services to any individual or entity whose business includes providing any of the
following Prohibited Services to others. This non-competition restriction is limited to individuals and entities that are located
in, or provide services in, the state or states in which Contractor worked or provided services for the Company during Contractor's
consultancy. For the purposes of this Agreement, “Prohibited Services” shall mean any other services provided by the
Company. This non-competition restriction covers services provided by Contractor whether as an employee for a Customer, consultant
for a third party, independent contractor, consultant, or any other status.

			 

Specific Performance

 

		28.	The
Contractor acknowledges that a breach or threatened breach by the Contractor of the provisions of Sections 14 to 30 of this Agreement
may result in the Parent and/or the Company and its shareholders suffering irreparable harm which cannot be calculated or fully
or adequately compensated by recovery of damages alone. Accordingly, the Contractor agrees that each of the Parent and the Company
shall be entitled to seek injunctive relief, specific performance and other equitable remedies, in addition to any other relief
to which either the Parent or the Company may become entitled.

 

Return of Property

 

		29.	Upon
the expiry or termination of this Agreement, the Contractor will return to the Company any property, documents, records, or Confidential
Information which is the property of the Company.

 

Capacity/Independent Contractor

 

		30.	In
providing the Services under this Agreement it is expressly agreed that the Contractor is acting as an independent contractor
and not as an employee. The Contractor and the Company acknowledge that this Agreement does not create a partnership or joint
venture between them, and is exclusively a contract for service.

 

Notice

 

		31.	All
notices, requests, demands or other communications required or permitted by the terms of this Agreement will be given in writing
and delivered to the Parties of this Agreement as follows:

 

	a.		Zomedica Pharmaceuticals, Corp.

3928 Varsity Drive

Ann Arbor, MI 48108

 

     

     

    

 

	c.		Dr. Willliam C. MacArthur 

Address 7373 Donegal Dr. 

Address Onsted, MI 49265

 

Or to such other address as any Party may from time to time notify
the other.

 

Indemnification

 

		32.	Except
to the extent paid in settlement from any applicable insurance policies, and to the extent permitted by applicable law, each Party
agrees to indemnify and hold harmless the other Party, and its respective directors, stockholders, affiliates, officers, agents,
employees, and permitted successors against any and all claims, losses, damages, liabilities, penalties, punitive damages, expenses,
reasonable legal fees and costs of any kind or amount whatsoever, which result from or arise out of any act or omission of the
indemnifying party, its respective directors, stockholders, affiliates, offices, agents, employees, and permitted successors that
occurs in connection with this Agreement. This indemnification will survive the termination of this Agreement.

 

Dispute Resolution

 

		33.	In
the event a dispute arises out of or in connection with this Agreement, the Parties will attempt to resolve the dispute through
friendly consultation.

 

		34.	If
the dispute is not resolved within a reasonable period then any or all outstanding issues may be submitted to mediation in accordance
with any statutory rules of mediation. If mediation is unavailable or is not successful in resolving the entire dispute, any outstanding
issues will be submitted to final and binding arbitration in accordance with the laws of the State of Delaware. The arbitrator’s
award will be final, and judgment may be entered upon it by any court having jurisdiction within the State of Delaware.

 

Modification of Agreement

 

		35.	Any
amendment or modification of this Agreement or additional obligation assumed by either Party in connection with this Agreement
will only be binding if evidenced in writing signed by each Party or an authorized representative of each Party.

 

Time of the Essence

 

		36.	Time
is of the essence in this Agreement. No extension or variation of this Agreement will operate as a waiver of this provision.

 

Assignment

 

		37.	The
Contractor will not voluntarily or by operation of law assign or otherwise transfer its obligations under this Agreement without
the prior written consent of the Company.

 

Entire Agreement

 

		38.	It
is agreed that there is no representation, warranty, collateral agreement or condition affecting this Agreement except as expressly
provided in this Agreement.

 

		39.	This
Agreement constitutes the entire agreement between the parties with respect to the topics expressly addressed herein, and supersedes
and replaces any and all other representations, understandings, negotiations, and previous agreements (including but not limited
to the Employment Agreement), whether written or oral, express or implied. The parties do not rely upon or regard as material
any representations or other agreements not specifically incorporated into and made part of this Agreement.

 

     

     

    

 

Titles/Headings

 

		40.	Headings
are inserted for the convenience of the Parties only and are not to be considered interpreting this Agreement.

 

Gender

 

		41.	Words
in the singular mean and include the plural and vice versa. Words in the masculine mean and include the feminine and vice versa.

 

Governing Law

 

		42.	It
is the intention of the Parties to this Agreement that this Agreement and the performance under this Agreement, and all suits
and special proceedings under this Agreement, be construed in accordance with and governed, to the exclusion of the law of any
other forum, by the laws of the State of Delaware, without regard to the jurisdiction in which any action or special proceeding
may be instituted.

 

Severability

 

		43.	In
the event that any of the provisions of this Agreement are held to be invalid or unenforceable in whole or in part, all other
provisions will nevertheless continue to be valid and enforceable with the invalid or unenforceable parts severed from the remainder
of this Agreement.

 

Waiver

 

		44.	The
waiver by either Party of a breach, default, delay or omission of any of the provisions of this Agreement by the other Party will
not be construed as a waiver of any subsequent breach of the same or other provisions.

 

Additional Considerations

 

		45.	Contractor
has acquired licenses to handle controlled substances in a research setting. Notice of relinquishment of these licenses will be
submitted to the appropriate agencies within 30 days of the execution of this Agreement.

 

		46.	Contractor
currently carries $2 million (two million US dollars) of key man insurance with the Company as a benefactor. This policy will
be discontinued, canceled, or otherwise rendered moot or ineffective within 5 business days of the execution of this Agreement.

 

		47.	Contractor
currently has his active veterinary license on record with vendors of the Company in order to enable the purchase of prescription
substances. Company will revoke the license of the Contractor from any and all vendors within 30 days of the execution of this
Agreement.

 

[The remainder of this page has been intentionally left blank]

 

 

     

     

    

 

IN WITNESS WHEREOF the parties have executed this Agreement as of the date and year first
above written.

 

 

 

	Zomedica Pharmaceuticals Corp. (the Parent)	 	Zomedica Pharmaceuticals Inc. (the
Company)
	 	 	 
	By: 	/s/ Gerald Solensky Jr.	 	By: 	/s/ Gerald Solensky Jr.
	 	 	 	 	 
	Name: 	Gerald Solensky Jr.	 	Name:  	Gerald Solensky Jr.
	 	 	 	 	 
	Title: 	Chairman, CEO	 	Title: 	CEO
	 	 	 
	 	 	 
	 	 	 
	Per: 	/s/ William MacArthur	 	Per: 	/s/ David Stowell
	 	Dr. William MacArthur	 	 	WitnessExhibit 10.16

 

 

 

 

 

 

EXECUTIVE EMPLOYMENT AGREEMENT

 

THIS AGREEMENT is made effective as
of the 1st day of July, 2017.

 

BETWEEN:

 

ZOMEDICA PHARMACEUTICALS INC., a body corporate duly incorporated
pursuant to the laws of the State of Delaware and having an office in the City of Ann Arbor, Michigan (hereinafter referred to
as the "Corporation")

 

- and -

BRUK HERBST,
an individual residing in 112 Ramblewood Lane, Adams Township, Pa. 16046 USA (hereinafter referred to as the "Executive")

 

 

ARTICLE
1

INTERPRETATION

 

		1.1	The phrase "this Agreement" shall include all terms and provisions of this agreement
in writing between the parties hereto, including the recitals.

 

		1.2	Wherever in this Agreement the masculine, feminine or neuter gender is used, it shall be construed
as including all genders, as the context so requires; and wherever the singular number is used, it shall be deemed to include the
plural and vice versa, where the context so requires.

 

		1.3	Time shall in all respects be of the essence of this Agreement.

 

		1.4	The division of this Agreement into Articles, Sections and subsections or any other divisions and
the inclusion of headings are for convenience only and shall not affect the construction or interpretation of all or any part hereof.

 

		1.5	Each party's rights may be exercised concurrently or separately and the exercise of any one remedy
shall not be deemed an exclusive election of such remedy or preclude the exercise of any other remedy.

 

ARTICLE
2

TERM OF AGREEMENT

 

		2.1	The term of this Agreement (the "Term") will begin on the date first written above (the
"Effective Date") and continue for one (1) year, unless terminated prior to then in accordance with this Agreement. This
Agreement shall automatically be extended from year to year, in one (1) year terms, unless either party elects not to extend this
Agreement by providing written notice of such non-extension to the other party at least ninety (90) days prior to the end of any
current Term.

 

     

     

    

 

ARTICLE
3

EMPLOYMENT OF THE EXECUTIVE

 

		3.1	The Corporation wishes to employ at the Effective Date the Executive as CCO ("Chief Commercial
Officer) and the Executive wishes to be employed at the Effective Date by the Corporation on the terms and conditions set forth
herein.

 

		3.2	The Executive shall report directly to the Corporation's Chief Executive Officer (the "CEO").

 

ARTICLE
4

PERFORMANCE OF DUTIES

 

		4.1	The Executive agrees to devote his business time, attention, skill and efforts to the faithful
performance and discharge of his duties and responsibilities as Chief Commercial Officer of the Corporation in conformity with
professional standards, in a prudent and workmanlike manner and in a manner consistent with the obligations imposed under applicable
law. The Executive shall promote the interests of the Corporation and each other corporation or other organization which is controlled
directly or indirectly by the Corporation and/or the Parent (as hereinafter defined) (each an "Affiliate" and collectively
the "Affiliates") in carrying out the Executive's duties and responsibilities and shall not deliberately and knowingly
take any action, or fail to take any action which failure could, or reasonably be expected to, have a material and adverse effect
on the business of the Corporation or any of its Affiliates.

 

		4.2	The Executive discloses, represents and affirms that he has no obligation toward any person or
entity, including former employers, that would be incompatible with this Agreement or that could create an impediment to or conflict
of interest with the performance of his duties with the Corporation and its affiliates.

 

		4.3	The Executive shall be appointed as Chief Commercial Officer of the Corporation's parent company,
Zomedica Pharmaceuticals Corp. (the "Parent"), an Alberta incorporated public company whose common shares are listed
and posted for trading on the TSX Venture Exchange. The Executive shall receive no compensation for his services under this Section
4.3 in addition to his compensation otherwise payable under this Agreement.

 

		4.4	The Corporation and the Executive agree that the Executive may continue to sit upon the board of
directors of any corporations or organizations on which he serves on the Effective Date as long as the CEO and the Executive mutually
agree that his membership on any such board of directors does not unreasonably interfere with the performance of Executive's duties
and responsibilities under this Agreement and, solely with the prior written authorization of the CEO, the Executive may serve
on any other board of directors.

 

ARTICLE
5

COMPENSATION

 

		5.1	Annual Base Salary. The Corporation shall pay the Executive a base annual salary (the "Base
Salary") which initially shall be ONE HUNDRED AND FIFTY THOUSAND DOLLARS US (US$150,000), subject to applicable taxable withholding
and deductions and payable in accordance with the Corporation's standard payroll practice for executive officers. The Base Salary
shall be reviewed annually by the Board or a committee of the Board and may be increased in accordance with the Corporation's compensation
policy.

 

		5.2	Quarterly Cash Bonus. The Executive shall be eligible to earn a quarterly cash bonus (the
"Quarterly Bonus"). Such Quarterly Bonus will be calculated upon the achievement of performance objectives that will
be established by the Board (as recommended by the Corporation's Compensation Committee) within thirty (30) days prior to the beginning
of a fiscal year. The granting of a Quarterly Bonus is also based on the business performance of the Corporation and subject to
approval by the Board. The Quarterly Bonus, if any, payable for any calendar year shall be paid no later than 30 days following
each Quarter. Finally, if the Executive's employment terminates (other than for Cause) on or after July 1 of a calendar year, he
shall be entitled to the payment of a pro rata part of any Quarterly Bonus, which would have been payable if he had continued to
be employed by the Corporation through the end of such calendar year.

 

     

     

    

 

		5.3	Monthly Allowance. The Corporation shall provide the Executive a monthly allowance in the
amount of FOUR THOUSAND DOLLARS US (US$4,000), which shall be paid as an allowance in respect of the following items: (i) vehicle;
and (ii) tax preparation. The foregoing amount shall be allocated among the foregoing items in such manner as the Executive determines,
subject to the approval of the CEO (acting reasonably).

 

		5.4	Business Expenses. The Corporation shall reimburse the Executive, upon presentation of valid
receipts or vouchers, for reasonable entertainment, travel, telephone and other business expenses (including but not limited to
expenses incurred in connection with computer repair/maintenance and office materials), incurred on behalf of or at the request
of the Corporation or an Affiliate and which are in accordance with the Corporation's policies and rules; provided, however:
(a) the amount of such expenses eligible for reimbursement in any calendar year shall not affect the expenses eligible for reimbursement
in another calendar year; (b) no right to such reimbursement may be exchanged or liquidated for another benefit or payment;
and (c) any reimbursements of such expenses shall be made as soon as practicable under the circumstances, but in any event no later
than the end of the calendar year following the calendar year in which the related expenses are incurred by the Executive.

 

		5.5	OTHER BENEFITS. Subject to eligibility requirements and participation rules, the Executive
may participate in all of the employee benefit plans maintained by the Corporation and its Affiliates that are available to employees
whose principal place of business is the same as the Executive's principal place of business.

 

ARTICLE
6

VACATION

 

		6.1	The Executive shall be entitled to a paid annual vacation of three (3) weeks in accordance with
the Corporation's vacation policy for executives. The Executive agrees that exercise of the vacation benefit shall be prearranged
in consultation with the CEO. The full annual vacation benefit shall be extended to the Executive for 2017.

 

ARTICLE
7

STOCK OPTIONS

 

		7.1	Initial Grant: Following the execution of this Agreement, the Executive shall be granted
200,000 options to acquire common shares in the capital of the Parent, with the price and terms of such options to be established
by the Board of Directors of the Parent in accordance with the Parent's stock option plan.

 

     

     

    

 

		7.2	Stock Options. In addition to the Base Salary, Quarterly Bonuses, benefits and other compensation
contemplated hereunder, the Executive shall also be eligible to receive future grants of stock options from the Parent, from time
to time, to the extent determined by the Board of Directors of the Parent at its sole discretion, which options shall vest in accordance
with a schedule to be determined by the Board of Directors of the Parent at its sole discretion, and which shall have an exercise
price equal to the market price of the Parent's common shares on the date of grant, or such higher price as may be required by
any stock exchange on which the shares of the Parent are listed, or if the Parent is not publicly traded, at such a price as shall
be determined by the Board of Directors of the Parent in its sole discretion. In addition to the initial grant of options contemplated
in Section 7.1 above, it is further acknowledged and agreed that the Executive shall be entitled to the following additional grants
of options to acquire common shares in the capital of the Parent: (i) 200,000 options upon the six (6) month anniversary of the
Effective Date, subject to completion of six (6) month performance objectives, as established by the CEO. The foregoing future
grants of stock options are contingent upon this Agreement being in full force and effect at the scheduled time of such option
grants (with no material breaches of this Agreement having occurred). The terms of such future stock option grants shall be determined
by the Board of Directors of the Parent at the time of grant and in accordance with the Parent's stock option plan and applicable
TSX Venture Exchange rules and policies. Any options granted to the Executive by the Board of Directors of the Corporation, or
pursuant to the terms of this Agreement, may be exercised only in accordance with the terms and conditions of the Stock Option
Agreement that is entered into in connection therewith.

 

		7.3	Accelerated Vesting. Subject to regulatory approval, the Corporation covenants and agrees
that any Stock Option Agreements between the Parent and the Executive shall provide that all stock options held by the Executive,
whether vested or unvested, shall immediately vest and be exercisable by the Executive upon a termination by the Corporation without
Cause as more specifically provided for in Article 8.2.

 

		7.4	Rules of the Stock Exchanges. The Corporation and the Executive expressly acknowledge and
agree that all options to purchase shares of the Parent to which the Executive shall be entitled hereunder, and any changes to
such options (including, without limitation, changes provided for in this Agreement), shall be subject to the approval and the
regulations, policies and by-laws of each of the stock exchanges on which the common voting shares of the Parent are then listed.
The Corporation covenants to use its reasonable commercial efforts to obtain any such approvals and to ensure that all options
are in compliance with such regulations, policies and by-laws.

 

ARTICLE
8

TERMINATION

 

		8.1	AtWill Employment. Nothing in this Agreement shall be construed to alter the atwill employment
relationship between the Corporation and the Executive. Subject to the terms set forth in this Agreement, either the Corporation
or the Executive may terminate the Executive's employment at any time for any reason, with or without Cause, as defined in Section
8.2 below.

 

		8.2	Termination for Cause. The Executive's employment may be terminated by the Corporation upon
simple notice in writing transmitted to the Executive, without the Corporation (or any of its Affiliates) being bound to pay any
compensation whatsoever if termination is for any of the following reasons, each of which constitutes cause (hereinafter, "Cause"):

 

		(a)	The Executive is declared bankrupt or insolvent or is placed under protective supervision, which
situations the Executive acknowledges to be incompatible with the continuation of his employment.

 

		(b)	The Executive becomes physically or mentally disabled to such an extent as to make him unable to
perform the essential functions of his duties normally and adequately for an aggregate of six (6) months during a period of twelve
(12) consecutive months. In such a case, the Executive may continue to benefit under shortterm and longterm disability insurance
plans, subject to the terms of such plans, if any. The Corporation's ability to terminate the Executive as a result of any disability
shall be to the extent permitted by applicable state or federal law.

 

     

     

    

 

		(c)	The Executive breaches the terms of this Agreement.

 

		(d)	The Executive fundamentally or materially fails to perform his duties as Executive Vice President
of the Corporation.

 

		(e)	There is a conclusive determination that the Executive has committed any fraud, theft, embezzlement
or other criminal act of a similar nature.

 

		(f)	The Executive has committed serious misconduct or willful or gross negligence in the performance
of his duties.

 

		(g)	The Executive fails or refuses to follow reasonable directives of the CEO.

 

		(h)	The Executive engages in willful or reckless conduct, causing material damage to the Corporation
or the Parent (or their Affiliates) or the Corporation's or the Parent's (or their Affiliates') business.

 

		(i)	The Executive misuses or abuses alcohol, drugs or controlled substances.

 

		(j)	The Executive uses or discloses in an unauthorized way the Corporation's or the Parent's (or any
of their Affiliates') confidential or trade secret information.

 

		(k)	The Executive conducts himself publicly, by speech or behavior, in such a manner as to cause public
embarrassment, scandal or ridicule to the Corporation or the Parent, any of their Affiliates or any of their employees.

 

Provided, however, no reason set forth
in this Section 8.2 shall constitute Cause unless (1) the Executive upon notice is given a reasonable period to effect a cure or
a correction; (2) the reason is curable or correctible as determined by the Board; and, (3) the reason clearly and adversely
affects the Executive's ability to continue to perform his duties and responsibilities under this Agreement.

 

		8.3	Termination by Death. In the event of the Executive's death during his period of employment,
the Corporation's obligation to make payments under this Agreement shall terminate on the date of death, except the Corporation
shall pay the Executive's estate or surviving designated beneficiary or beneficiaries, as appropriate, any earned but unpaid salary
and bonus and reimburse business expenses incurred but not reimbursed as of his date of death. Vesting of any stock options outstanding
on the date of death shall be exercisable only to the extent the Executive's right to exercise was vested on his date of death.

 

		8.4	Voluntary Termination. In the event Executive wishes to resign for any reason or the Corporation
wishes to terminate his employment without Cause, the Executive shall give, or receive, as applicable at least thirty (30) days
prior written notice of such resignation or termination, whichever is applicable. Any such notice shall not relieve either the
Executive or the Corporation of their mutual obligations to perform under this Agreement or to relieve the Corporation to compensate
the Executive during such notice period for any earned but unpaid salary and bonus and reimburse business expenses incurred but
not reimbursed as of his date of termination.

 

     

     

    

 

		8.5	Termination Without Cause. In the event that the Executive has a "separation from service"
within the meaning of a §409A of the US Internal Revenue Code of 1986, as amended (a "Separation from Service")
as a result of the Corporation terminating the Executive's employment without Cause at a date that is at least twelve (12) months
following the Effective Date, (1) Executive's right to exercise all then outstanding stock options granted to him shall fully and
immediately vest on the effective date of his Separation from Service; (2) the Corporation shall pay to Executive in a lump
sum (less applicable tax withholdings) an amount equal to: (i) twelve (12) months Base Salary
(paid  in  accordance  with  the  Corporation's usual
payroll procedures); and (ii) any Quarterly Bonus allocable or payable
prior to the date of termination.

 

ARTICLE
9

CONFIDENTIALITY

 

		9.1	The Executive acknowledges that he has received and will receive or conceive, in carrying on or
in the course of his work during his employment with the Corporation, confidential information pertaining to the activities, the
technologies, the operations and the business, past, present and future, of the Corporation or its affiliates or related or associated
companies, which information is not in the public domain. The Executive acknowledges that such confidential information belongs
to the Corporation and/or its affiliates and that its disclosure or unauthorized use could be damaging or prejudicial to the Corporation
and/or its affiliates and contrary to their best interests.

 

		9.2	Accordingly, the Executive agrees to respect the confidentiality of such information and not to
make use of or disclose it to, or to discuss it with, any person, other than in the ordinary course of his duties with the Corporation
and its Affiliates, or as required under applicable law, without the explicit prior written authorization of the Corporation.

 

		9.3	This undertaking to respect the confidentiality of such information and not to make use of or disclose
or discuss it to or with any person shall survive and continue to have full effect notwithstanding the termination of the Executive's
employment with the Corporation, so long as such confidential information does not become public as a result of an act by the Corporation
or a third party, which act does not involve the fault of one of its executives.

 

		9.4	The term confidential information includes, among other things:

 

		(a)	products, formulae, processes and composition of products, as well as raw materials and ingredients,
of whatever kind, that are used in their manufacture;

 

		(b)	technical knowledge and methods, quality control processes, inspection methods, laboratory and
testing methods, information processing programs and systems, manufacturing processes, plans, drawings, tests, test reports and
software;

 

		(c)	equipment, machinery, devices, tools, instruments and accessories;

 

		(d)	financial information, production cost data, marketing strategies, raw materials supplies, suppliers,
staff and client lists and related information, marketing plans, sales techniques and policies, including pricing policies, sales
and distribution data and present and future expansion plans; and

 

		(e)	research, experiments, inventions, discoveries, developments, improvements, ideas, industrial secrets
and knowhow.

 

     

     

    

 

		9.5	The Executive agrees to keep confidential and not disclose to any third party both the existence
and the terms of this Agreement, except if disclosure is required by regulation or law. In the event that the Executive is required
to disclose the existence or terms of this Agreement pursuant to subpoena or other duly issued court order, Executive shall give
prompt notice to the Corporation of such subpoena or court order to allow the Corporation sufficient opportunity to contest such
subpoena or court order.

 

ARTICLE
10

NON-SOLICITATION OF OFFERS

 

		10.1	The Executive shall not compete with the Corporation nor with any of its Affiliates, directly or
indirectly. He shall not participate in any capacity whatsoever in a business that would directly or indirectly compete with the
Corporation or with any of its Affiliates, including, without limitation, as an executive, director, officer, employer, principal,
agent, fiduciary, administrator of another's property, associate, independent contractor, franchisor, franchisee, distributor or
consultant unless such participation is fully disclosed to the Board and approved in writing in advance. In addition, the Executive
shall not have any interest whatsoever in such an enterprise, including, without limitation, as owner, shareholder, partner, limited
partner, lender or silent partner. This noncompetition covenant is limited as follows:

 

		(a)	As to the time period, to the duration of the Executive's employment and for a period of
two (2) years following the date of termination of his employment;

 

		(b)	As to the geographical area, the territory in which a specific product had been actively
exploited by the Corporation and/or its Affiliates during the twenty-four (24) months preceding the employment termination date;

 

		(c)	As to the nature of the activities, to duties or activities which are identical or substantially
similar to those performed or carried on by the Executive at or during the twenty-four (24) months preceding the employment termination
date.

 

		10.2	The foregoing stipulation shall nevertheless not prevent the Executive from buying or holding shares
or other securities of a corporation or entity other than the Corporation whose securities are publicly traded on a recognized
stock exchange where the securities so held by the Executive do not represent more than five percent (5%) of the voting shares
of such other corporation or entity and do not allow for its control.

 

		10.3	The Executive also undertakes, for the same period and in respect of the same territory referred
to hereinabove in subsections 10.1(a), (b) and (c), not to solicit clients or do anything whatsoever to induce or to lead any person
to end, in whole or in part, business relations with the Corporation or any of its affiliates.

 

		10.4	The Executive also undertakes, for the same period and in respect of the same territory referred
to hereinabove in subsections 10.1(a), (b) and (c), not to induce, attempt to induce or otherwise interfere in the relations which
the Corporation or which any of its affiliates has with their distributors, suppliers, representatives, agents and other parties
with whom the Corporation or any of its affiliates deals.

 

		10.5	The Executive also undertakes, for the same period and in respect of the same territory referred
to in subsections 10.1(a), (b) and (c), not to induce, attempt to induce or otherwise solicit the personnel of the Corporation
to leave their employment with the Corporation or any of its Affiliates nor to hire the personnel of the Corporation or any of
its Affiliates for any enterprise in which the Executive has an interest.

 

     

     

    

 

		10.6	The Executive acknowledges that the provisions of this Section 10 are limited as to the time period,
the geographic area and the nature of the activities to what the parties deem necessary to protect the legitimate interests of
the Corporation and its Affiliates, while allowing the Executive to earn his living.

 

		10.7	Nothing in this Section 10 shall operate to reduce or extinguish the obligations of the Executive
arising at law or under this contract which survive at the termination of this Agreement in reason of their nature and, in particular,
without limiting the foregoing, the Executive's duty of loyalty and obligation to act faithfully, honestly and ethically.

 

ARTICLE
11

OWNERSHIP OF INTELLECTUAL PROPERTY

 

		11.1	The Executive hereby assigns and agrees to assign to the Corporation all of his intellectual property
rights as of their creation and to make full and prompt disclosure to the Corporation of all information relating to anything made
or designed by him or that may be made or designed by him during the period of his employment, whether alone or jointly with other
persons, or within a period of two (2) years following the termination of his employment and resulting from or arising out of any
work performed by the Executive on behalf of the Corporation (or its affiliates) or connected with any matter relating or possibly
relating to any business in which the Corporation or any of its affiliates or related or associated companies is involved unless
specifically released from such obligation in writing by the Corporation's Board of Directors.

 

		11.2	In addition, the Executive renounces all moral rights in any document or work realized during the
period of his employment related to his employment by the Corporation. The Executive acknowledges that the Corporation has the
right to use, modify or reproduce any such document or work realized by the Executive, at its entire discretion, without the Executive's
authorization and without his name being mentioned.

 

		11.3	At any time during the period of his employment or after the termination of his employment, the
Executive shall sign, acknowledge and deliver, at the Corporation's expense, but without compensation other than a reasonable sum
for his time devoted thereto if his employment has then terminated, any document required by the Corporation to give effect to
Section 11.1, including patent applications and documents evidencing the assignment of ownership. The Executive shall also provide
such other assistance as the Corporation or one of its affiliates may require with respect to any proceeding or litigation relating
to the protection or defense of intellectual property rights belonging to the Corporation or any of its affiliates. The entirety
of this Section 11 shall be binding on the Executive's assignees and legal representatives.

 

ARTICLE
12

OWNERSHIP OF FILES AND OTHER PROPERTY

 

		12.1	Any property of the Corporation, including any file, sketch, drawing, letter, report, memorandum
or other document, any equipment, machinery, tool, instrument or other device, any diskette, recording tape, compact disc, software,
electronic communication device or any other property, which comes into the Executive's control or possession during his employment
with the Corporation in the performance or in the course of his duties, regardless of whether he has participated in its preparation
or design, how it may have come under his control or into his possession and whether it is an original or a copy, shall at all
times remain the property of the Corporation and, upon the termination of the Executive's employment, shall promptly be returned
to the Corporation or its designated representative.. The Executive may not keep a copy or give one to a third party without the
prior expressly written permission of the Corporation.

 

     

     

    

 

 

ARTICLE
13

ENTIRE AGREEMENT AND TERMINATION OF PRIOR CONTRACTS

 

		13.1	This Agreement contains the entire understanding of the parties with respect to the matters contained
or referred to herein. There are no promises, covenants or undertakings by either party hereto to the other, other than those expressly
set forth herein. This Agreement supersedes and replaces any earlier agreement, whether oral or in writing or partly oral and partly
in writing, between the parties hereto, or between any party hereto and the corporate representative of any other party hereto,
respecting the provision of services by the Executive to the Corporation.

 

ARTICLE
14

AMENDMENT OF THE AGREEMENT

 

		14.1	To be valid and enforceable, any amendment to this Agreement must be confirmed in writing by each
of the Corporation and the Executive.

 

ARTICLE
15

NOTICES

 

		15.1	Any notice given hereunder shall be given in writing and sent by registered or certified mail or
handdelivered. If such notice is sent by registered or certified mail, it shall be deemed to have been received five (5) business
days following the date of its mailing if the postal services are working normally. If such is not the case, the notice must be
handdelivered or served by bailiff, at the discretion of the sender. In the case of handdelivery or service, the notice shall be
deemed to have been received the same day. It is agreed that if the delivery date is a non business day, the notice shall be deemed
to have been received on the following business day.

 

		15.2	For purposes of mailed or handdelivered notices to be effectively delivered under this provision,
the notices must be addressed as follows:

 

		(a)	For the Corporation: 1250, 639 – 5th Avenue S.W., Calgary, Alberta T2P 0M9.

		(b)	For the Executive: 112 Ramblewood Lane, Adams Township. Pa. 16046

 

ARTICLE
16

INDEMNITY AND INSURANCE

 

		16.1	The Corporation covenants, both during and after the Executive's term of service, to indemnify
and hold harmless the Executive and his legal representatives, to the maximum extent permitted by Delaware law (provided that the
Executive acted honestly and in good faith with a view to the best interests of the Corporation and, in the case of a criminal
or administrative action or proceeding that is enforced by monetary penalty, the Executive had reasonable grounds for believing
that his conduct was lawful), from and against:

 

		(a)	all costs, charges, liabilities and expenses whatsoever that the Executive may sustain or incur
in or about or in relation to any action, suit or proceeding that is brought, commenced or prosecuted against the Executive for
or in respect of any act, deed, matter or thing whatever made, done or permitted or not made, done or permitted by the Executive
in or about the execution of his duties as a director or officer of the Corporation or its subsidiaries; and

 

		(b)	all other costs, charges, liabilities and expenses that the Executive may sustain or incur (including,
without limitation, all income tax, sales tax and excise tax liabilities resulting from any payment made pursuant to this indemnity)
in or about or in relation to the affairs of the Corporation or its subsidiaries or his position as a director or officer of the
Corporation or its subsidiaries.

 

     

     

    

 

		16.2	The Corporation further agrees that any costs, charges and expenses referred to in paragraph 16.1(a)
above shall be paid in advance of the final disposition of any such action or proceeding upon receipt by the Corporation of a written
undertaking by the Executive to repay such amount if it shall ultimately be determined that the Executive is not entitled to be
indemnified in accordance with the terms and conditions of this Indemnity and Delaware law.

 

		16.3	The Corporation further agrees, both during and after the Executive's term of service, to use its
reasonable best efforts to obtain any approval or approvals necessary for such indemnification and to co-operate with the Executive
and to provide the Executive with access to any evidence which the Corporation may have or control, which would enable the Executive
to make application or obtain any approval or approvals necessary for such indemnification.

 

ARTICLE
17

SUCCESSORS

 

		17.1	This Agreement shall be binding on the successors, assignees and legal representatives of all of
the parties hereto.

 

ARTICLE
18

JURISDICTION

 

		18.1	This Agreement shall be governed by and interpreted in accordance with the laws, including conflicts
of laws, by the State of Delaware in the United States of America. Each of the parties hereby irrevocably attorns to the jurisdiction
of the Courts of the State of Delaware with respect to any matters arising out of this Agreement.

 

ARTICLE
19

SEVERABILITY

 

		19.1	If any provision of this Agreement or the application thereof is held invalid, the invalidity shall
not affect other provisions or applications of this Agreement, which can be given effect without the invalid provisions or applications
and, to this end, the provisions of this Agreement are declared to be severable.

 

ARTICLE
20

MEDIATION

 

		20.1	The Corporation and the Executive hereby expressly agree that with respect to any dispute arising
under this Agreement, such dispute shall be resolved through binding mediation. Any such mediation shall: (1) take place at a location
mutually agreed upon by the Corporation and the Executive; and (2) be conducted by a recognized panel of three professional
mediators or which can be comprised of three experienced business experts from the pharmaceutical or biotechnical industry mutually
agreed upon by the Corporation and the Executive. With respect to any such mediation panel, one mediator shall be selected by the
Corporation, one mediator shall be selected by the Executive, and one mediator shall be selected by mutual agreement between the
Corporation and the Executive. Each of the parties hereto shall bear their own, respective costs of such mediation.

 

     

     

    

 

ARTICLE
21

LANGUAGE

 

		21.1	All of the parties hereto expressly agree that this Agreement be drafted, read and interpreted
in the English language.

 

ARTICLE
22

GENERAL

 

		22.1	This Agreement and the obligations of the Executive hereunder shall not be assigned by either party
hereto, in whole or in part, without the prior consent of the other party hereto, which consent may be withheld for any reason.

 

		22.2	Each party shall do and perform all such acts and things and execute and deliver all such instruments
and documents and writings and give all such further assurances as may be necessary to give full effect to the provisions and intent
of this Agreement.

 

		22.3	The Executive agrees that after termination of employment hereunder for any reason whatsoever,
he will tender his resignation from any position he may hold as an officer or director of the Corporation, the Parent or their
Affiliates.

 

		22.4	This Agreement shall enure to the benefit of and be binding upon the Executive and his executors
and administrators and upon the Corporation and its successors and assigns.

 

		22.5	Neither party can waive or shall be deemed to have waived any right it has under this Agreement
(including any waiver under this section) except to the extent that such waiver is in writing.

 

		22.6	The Corporation agrees to co-operate with the Executive, to the extent permitted by applicable
tax laws, so as to permit the Executive to consider payments hereunder on termination of employment to be retirement benefits.

 

ARTICLE
23

COUNTERPARTS

 

		23.1	This Agreement may be executed in counterparts, each of which shall be deemed one and the same
Agreement.

 

[Reminder of page intentionally left blank.]

 

     

     

    

 

 

IN WITNESS WHEREOF the parties have executed this
Agreement as of the date and year first above written.

 

	 	 	ZOMEDICA PHARMACEUTICALS CORP.	 
	 	 	 	 	 
	 	 	Per:	/s/ Gerald Solensky Jr.	 
	 	 	 	Gerald Solensky Jr.	 
	 	 	 	Chairman, CEO	 
	 	 	 	 	 
	 	 	 	 	 
	/s/ David Stowell	 	 	/s/ Bruk Herbst	 
	Witness	 	 	bruk herbst	 
	Name: David Stowell

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}]]